High prevalence of obesity in rheumatoid arthritis patients: association with disease activity, hypertension, dyslipidemia and diabetes, a multi-center study

Abstract

Introduction: Rheumatoid arthritis (RA) is a well-documented independent risk factor for cardiovascular disease. Obesity may provide an additional link between inflammation and accelerated atherosclerosis in RA. Objective: To evaluate the association between obesity and disease parameters and cardiovascular risk factors in RA patients. Method: Cross-sectional study of a cohort of RA patients from three Brazilian teaching hospitals. Information on demographics, clinical parameters and the presence of cardiovascular risk factors was collected. Blood pressure, weight, height and waist circumference (WC) were measured during the first consultation. Laboratory data were retrieved from medical records. Obesity was defined according to the NCEP/ATPIII and IDF guidelines. The prevalence of obesity was determined cross-sectionally. Disease activity was evaluated using the DAS28 system (remission < 2.6; low 2.6-3.1; moderate 3.2-5.0; high > 5.1). Results: The sample consisted of 791 RA patients aged 54.7 ± 12.0 years, of whom 86.9% were women and 59.9% were Caucasian. The mean disease duration was 12.8 ± 8.9 years. Three quarters were rheumatoid factor-positive, the mean body mass index (BMI) was 27.1 ± 4.9, and the mean WC was 93.5 ± 12.5 cm. The observed risk factors included dyslipidemia (34.3%), type-2 diabetes (15%), hypertension (49.2%) and family history of premature cardiovascular disease (16.5%). BMIdefined obesity was highly prevalent (26.9%) and associated with age, hypertension and dyslipidemia. Increased WC was associated with diabetes, hypertension, dyslipidemia and disease activity. Conclusion: Obesity was highly prevalent in RA patients and associated with disease activity.

Health effects of a low-inflammatory diet in adults with arthritis: a systematic review and meta-analysis

“…Obesity is common among those who suffer from OA (51) and RA (52,53) . In the meta-analysis, one study (44) specifically recruited obese patients with knee OA, while another study's baseline characteristics indicate the inclusion of obese participants (42) .…”

Involvements of long noncoding RNAs in obesity‐associated inflammatory diseases

“…RA is a chronic inflammatory autoimmune disease where abdominal adiposity is prevalent amongst 20%-50% of patients. 108 Immune dysfunction in RA leads to destruction of bone and cartilage, immune cell infiltration and inflammation. 109 Several lncRNAs have been recognized to influence inflammatory pathways such as NF-κB signalling, p38 MAPK and toll-like receptor pathways in RA.…”

Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic

“…This can be closely associated with obesity. At least a quarter of RA patients are overweight (BMI > 25) [ 62 ]. Besides being a direct risk factor, it also contributes indirectly by increasing disease activity and making remission more difficult to achieve [ 99 ].…”